2-(4-溴苯基)乙基异丁酯 | 730964-66-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-溴苯基)乙基异丁酯
• 英文名称: 2-(4-bromophenyl)ethylisocyanide
• 英文别名: 1-bromo-4-(2-isocyanoethyl)benzene
• CAS: 730964-66-6
• 化学式: C₉H₈BrN
• 分子量: 210.073
• InChiKey: OAAQPFXPFMGDAT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  4.4
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  2-(4-溴苯基)乙基异丁酯 在 甲烷磺酸 作用下， 以 甲醇 为溶剂， 反应 54.0h， 生成 10-bromopraziquantel
  参考文献：
  名称：

  具有抗血吸虫病活性的吡喹酮衍生物：芳香环修饰。

  摘要：

  制备了一系列芳香环修饰的吡喹酮衍生物，并针对日本血吸虫的少年期和成年期进行了评估。根据体外和体内的日本血吸虫血吸虫血吸虫蠕虫活力测定法，已鉴定出几种活性与药物吡喹酮相当的类似物。揭示了这些吡喹酮芳香环改性化合物的结构和活性关系。具体地，在吡喹酮的芳香环中引入了溴的化合物在体内显示出对吡喹酮的紧密的抗血吸虫病活性。

  DOI：

  10.1111/cbdd.12153
• 作为产物：
  描述：

  4-溴苯乙胺 在 三乙胺 、 三氯氧磷 作用下， 以 二氯甲烷 为溶剂， 反应 15.5h， 生成 2-(4-溴苯基)乙基异丁酯
  参考文献：
  名称：

  具有抗血吸虫病活性的吡喹酮衍生物：芳香环修饰。

  摘要：

  制备了一系列芳香环修饰的吡喹酮衍生物，并针对日本血吸虫的少年期和成年期进行了评估。根据体外和体内的日本血吸虫血吸虫血吸虫蠕虫活力测定法，已鉴定出几种活性与药物吡喹酮相当的类似物。揭示了这些吡喹酮芳香环改性化合物的结构和活性关系。具体地，在吡喹酮的芳香环中引入了溴的化合物在体内显示出对吡喹酮的紧密的抗血吸虫病活性。

  DOI：

  10.1111/cbdd.12153

文献信息

• Bi-functional complexes and methods for making and using such complexes
  申请人：Gouliaev Alex Haahr

  公开号：US11225655B2

  公开（公告）日：2022-01-18

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.

  本发明涉及一种合成双功能复合物的方法，该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行，此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接，合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
• Synthesis of 1,2,4-triazoles employing isocyanides
  作者：Pakornwit Sarnpitak、Mikhail Krasavin

  DOI：10.1016/j.tet.2013.01.039

  日期：2013.3

  A conceptually new, two-step synthesis of medicinally important 1,2,4-triazoles from isocyanides and thiosemicarbazones was developed. The method is based on the recently discovered TMSCI-promoted reaction of isocyanides that yields rare N-1,N-3-disubstututed formamidrazones. (C) 2013 Elsevier Ltd. All rights reserved.
• BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
  申请人：Nuevolution A/S

  公开号：EP2558577A1

  公开（公告）日：2013-02-20
• BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
  申请人：Gouliaev Alex Haahr

  公开号：US20130281324A1

  公开（公告）日：2013-10-24

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
• [EN] BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES<br/>[FR] COMPLEXES BIFONCTIONNELS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE TELS COMPLEXES
  申请人：NUEVOLUTION AS

  公开号：WO2011127933A1

  公开（公告）日：2011-10-20

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.